Liofilchem, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Liofilchem, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Liofilchem, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jul 23, 2026 to Jul 23, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code JTN appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 465 Waverley Oaks Rd., Suite 317, Waltham, MA, 02452, US. Recorded on K261853, decision dated Jul 23, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Gepotidacin GEP 10 µg
K261853 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.